Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ARQL - ArQule: Profiting From Tyrosine Kinase Inhibition


ARQL - ArQule: Profiting From Tyrosine Kinase Inhibition

Time is the friend of the wonderful company, the enemy of the mediocre. - Warren Buffett

Aside from his prowess for numbers, Warren Buffett has the excellent temperament for investment. In my view, Buffett's mega success is the cumulation of his hard work and rigorous learning. With a voracious appetite for knowledge, Buffett reads financial reports daily in his office. The man is a learning machine. That aside, the fact that Buffett lives in the golden land of opportunity also helps him grow Berkshire Hathaway (BRK.A) to become a multibillion-dollar franchise. In following the footsteps

Read more ...

Stock Information

Company Name: ArQule Inc.
Stock Symbol: ARQL
Market: NASDAQ
Website: arqule.com

Menu

ARQL ARQL Quote ARQL Short ARQL News ARQL Articles ARQL Message Board
Get ARQL Alerts

News, Short Squeeze, Breakout and More Instantly...